Exercise Training for Brachial Plexus Injury
Trial Summary
What is the purpose of this trial?
Although peripheral nerve is capable of regrowth following injury, at only 1 mm/day, the slow rate represents a major barrier. Apart from rapid deterioration of the environment supportive of growth, denervated muscles become atrophic and bones osteoporotic. To successfully restore function, in addition to speeding up the nerve regeneration rate, treatments that can also restore muscle and bone mass are essential. Recently, in animal studies, the investigators showed that in addition to accelerating the speed of nerve regeneration, exercise training can also be used to restore muscle bulk and bone density. While promising, given the inter-species differences, the clinical utilities of this treatment need to be directly tested in humans. This will be done using a randomized controlled study design on patients with brachial plexus injury.
Research Team
Eligibility Criteria
This trial is for adults aged 18-60 with a specific nerve injury in the arm called brachial plexus injury, confirmed by special nerve tests. Participants must be able to give consent. Those with other conditions affecting arm and hand function cannot join.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Exercise Training (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alberta
Lead Sponsor
Bill Flanagan
University of Alberta
Chief Executive Officer since 2020
LLB from University of Toronto, LLM from Columbia University
Dr. Verna Yiu
University of Alberta
Chief Medical Officer since 2012
MD from University of Alberta, Fellowship in Pediatric Nephrology at Harvard University
Royal Alexandra Hospital
Collaborator
Glenrose Foundation
Collaborator